The importance of non-motor symptoms in the clinical picture of motor neuron disease

Non-motor symptoms are an obligate sign of motor neuron disease and can often serve as a rather sensitive indicator of the general functional state of ALS patients. Gastrointestinal disorders, weight loss, pain, sweating and anxiety prevail in the structure of non-motor symptoms in ALS patients.

The presence of non-motor symptoms in patients indicates the multisystemic nature of this fatal disease.

The use of Non-Motor Symptom Scale (NMS) in patients with ALS in the early stages will allow neurologists to detect non-motor symptoms timely.

Key words: amyotrophic lateral sclerosis, non-motor symptoms, non-motor symptoms scale, edaravone, ALSFRS-R scale.

11 January, 2021

Authors:

Golovchenko Y.I. В. В. КОСТЕНКО

Products:

Xavron

Learn more

Uncategorized

Vascular neurological complications in patients with COVID-19

Uncategorized

Astenic syndrome in a post-covid-19 patient (review and own experience)

Among the symptoms and syndromes that dominate the clinical picture of postcoid syndrome (POST-COVID-19), the signs of asthenia, increased fatigue, excessive exhaustion during normal daily activities, which form asthenic syndrome, are highlighted. For the treatment of postcoid asthenic syndrome, a combination of pathogenetically justified agents has been proposed: podaravone (Xavron), a mixture of L-arginine and...
Uncategorized

” Long-haulers “: patients with post-covid syndrome in routine clinical practice

At the beginning of the COVID 19 pandemic, SARS-CoV 2 disease was thought to be transient (like most respiratory viral infections). The World Health Organization later reported that the duration of a new coronavirus disease from the onset of the first symptoms to mild clinical recovery is ≈2 weeks, and in severe or moderate cases,...
Uncategorized

Modern possibilities of infusion therapy in patients with diabetic ketoacidosis

Summary. The mechanisms of development and clinical manifestations of diabetic ketoacidosis (DKA) are analyzed in the article, the infusion therapy program is presented, the prospects of the use of xylitol-based infusions in the treatment of DKA are discussed. The authors also presented their own experience with the use of Xylat solution. It has been shown...
Uncategorized

Japanese experience in the treatment of patients with acute ischemic stroke. Interview with Professor Yukito Shinohara

Uncategorized

The use of the drug Xavron (Edaravon) in the complex treatment of patients with ischemic stroke in combination with thrombolytic therapy